Patents
Patents for C07D 271 - Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms (7,144)
04/2006
04/19/2006EP1177176B1 Tri-aryl acid derivatives as ppar receptor ligands
04/19/2006CN1252047C Benzene sulfonic derivative
04/18/2006US7030116 Compounds and compositions as cathepsin inhibitors
04/18/2006CA2360943C N2-phenylamidine derivatives
04/13/2006US20060079562 Heterocyclic aromatic compounds useful as growth hormone secretagogues
04/13/2006US20060079527 Compounds such as 1-[4-(3,4-difluoro-phenyl) -piperazin-1 -yl]-3-{methyl-[2-(9H-xanthen-9-yl)-ethyl]-amino}-propan-1 -one in free base or acid addition salt form, for therapy of depression, anxiety and bipolar disorders
04/12/2006EP1644320A1 Indane derivates as muscarinic receptor agonists
04/12/2006EP1343771B1 3-ox(adi)azolylpropanohydroxamic acids useful as procollagen c-proteinase inhibitors
04/12/2006CN1759105A Insecticidal phthalamide derivatives
04/12/2006CN1759104A Non-nucleoside reverse transcriptase inhibitors I for treating HIV mediated diseases
04/12/2006CN1250735C Method for production of non-proteinogen L-amino acid by fermentation
04/12/2006CN1250539C Intermediate for preparing 1-[halogenarylradical] heterocyclic pesticide compound
04/11/2006US7026500 Halogenated selective androgen receptor modulators and methods of use thereof
04/11/2006CA2181570C Metalloproteinase inhibitors
04/05/2006EP1641452A1 Heterocyclic compounds useful to treat hcv
04/05/2006CN1249060C Heterofluorene derivative with strong two photon absorption character
04/04/2006CA2256492C Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists
03/2006
03/30/2006WO2006016724A3 Liquid-crystalline compounds, compositions and thin films
03/30/2006WO2005120515A3 Novel sulfonamides as inhibitors of histone deacetylase for the treatment of disease
03/30/2006US20060069255 Novel aryl ureido benzoic acid derivatives and their use
03/30/2006CA2580787A1 Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-coa desaturase enzymes
03/29/2006EP1638928A1 N-alkynyl-2-(substituted aryloxy)alkylthioamide derivatives as fungicides
03/29/2006CN1247544C Anthranilic acid amides with heteroarylsulfonyl side chain and use thereof as active substance for antiarythmia
03/28/2006US7019147 E.,g.,1-[2-(5-Methoxy-benzoimidazol-1-yl)-quinolin-8-yl]-piperidin-4-ylamine; anticarcinogenic and -tumor agent; KDR tyrosine kinase inhibitors; (KDR=kinase inserrt domain recepter)
03/28/2006CA2395186C Procollagen c-proteinase inhibitors
03/23/2006WO2006030211A2 Acyclic sulphonamides
03/23/2006WO2006029906A1 Methylene dipiperidine derivatives
03/23/2006US20060063843 Compounds for the treatment of inflammatory disorders
03/23/2006US20060063772 New compounds
03/23/2006US20060063765 5-[({[({(2S)-4-[(3,4-dichlorophenyl)methyl]-2-morpholinyl}methyl)amino]carbonyl}amino)methyl]-N-methyl-3-furancarboxamide; free of N-{[4-(3,4-dichlorobenzyl)morpholin-2-yl]methyl}-N'-(2-furylmethyl)urea; CCR3/chemokine recetptor/ antagonists
03/23/2006CA2576057A1 Mitotic kinesin inhibitors
03/22/2006EP1635824A2 5-membered heterocycle-based p-38 inhibitors
03/22/2006EP1029541B1 Therapeutic or prophylactic agent for glomerulopathy
03/22/2006CN1751037A Sulfonamide derivatives as PPAR modulators
03/21/2006US7015331 A compound selected from the group consisting of 1,2,3-benzotriazol-2-yl-L-alanine, 5-carboxy-1,2,3-benzotriazol-2-yl-L-alanine, and 5-carboxy-1,2,3-benzotriazol-1-yl-L-alanine.
03/16/2006US20060058524 coupling aromatic or heteroaromatic halogen compounds to form one or more C C single bonds, characterized in that an Ni(0) complex comprising at least two different ligands
03/16/2006US20060058298 Inhibitors of histone deacetylase
03/15/2006CN1747944A Blue light-emitting compound, method for producing same and light-emitting device utilizing same
03/15/2006CN1747942A Heterocyclic compounds useful as nurr-1 activators
03/15/2006CN1746163A 2,5-diaryl substituting group-1,3,4-oxidazole derivative, its synthesis and use
03/15/2006CN1245381C Phenylglycine derivatives
03/14/2006US7012075 Cathepsin cysteine protease inhibitors
03/14/2006CA2359363C 4-(heterocyclylsulfonamido)-5-methoxy-6-(2-methoxyphenoxy)-2-phenyl- or pyridylpyrimidines as endothelin receptor antagonists
03/09/2006WO2006025219A1 Novel polymer, novel compound, method for producing novel polymer, method for producing novel compound, and blue light-emitting device
03/09/2006US20060052445 Diarylsulfones as 5-HT2A antagonists
03/09/2006US20060052423 Peptide deformylase inhibitors
03/09/2006US20060052358 Modulators of ATP-binding cassette transporters
03/09/2006US20060051879 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
03/09/2006DE10231627B4 Heterozyklisch substituierte Benzoylharnstoffe und ihre Verwendung als Arzneimittel Heterocyclic unsubstituted benzoyl ureas and their use as a medicament
03/08/2006EP1631542A1 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof
03/08/2006EP1482924A4 Cathepsin cysteine protease inhibitors
03/08/2006EP1261591B1 7-nitro-2,1,3-benzoxadiazole derivatives and 7-nitro-2,1,3-benzthiadiazole derivatives and dyes, which contain these compounds and which are used for dying keratin fibers
03/02/2006WO2006021806A1 Arylsulphonylstilbene derivatives for treatment of insomnia and related conditions
03/02/2006WO2006021805A1 Diarylsulfones as 5-ht2a antagonists
03/02/2006CA2577837A1 Diarylsulfones as 5-ht2a antagonists
03/01/2006CN1742002A Novel piperazine derivatives and their use as synthesis intermediates
02/2006
02/28/2006US7005450 2-amino-2-alkyl-4 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors
02/28/2006US7005440 Therapeutic uses of tri-aryl acid derivatives
02/22/2006EP1627872A1 Process for the synthesis of the potassium salt of dinitrobenzofuroxane
02/22/2006CN1738797A Substituted aryl thioureas and related compounds; inhibitors of viral replication
02/22/2006CN1736981A Selective androgen receptor modulators and methods of use thereof
02/22/2006CN1736371A Selective androgen receptor modulators and methods of use thereof
02/21/2006US7001909 For therapy of cardiovascular diseases such as atrial and ventricular arrhythmias, intermittent claudication, Prinzmetal's (variant) angina, stable and unstable angina, exercise induced angina, congestive heart disease
02/16/2006US20060036097 Oxadiazole metallic complexes and their electronic and opto-electronic applications
02/16/2006US20060035943 E.g., 3-(5-p-tolyl-[1,2,4]oxadiazol-3-yl)-benzoic acid; treating or preventing a disease ameliorated by modulation of premature translation termination or nonsense-mediated mRNA decay such as genetic disorders
02/16/2006CA2575430A1 1,3-disubstituted heteroaryl nmda/nr2b antagonists
02/16/2006CA2573369A1 Inhibitors of histone deacetylase
02/14/2006US6998423 Sulfonyl-amino or carbonyl-amino derivatives; osteoporosis bone disorders; therapeutic drug or kits including anti-resorptive agents, anabolic agents;
02/09/2006US20060030599 Sulphonamide derivatives
02/09/2006US20060030553 Cell adhesion inhibitors
02/09/2006CA2576028A1 Heterocyclic compounds useful as dpp- iv inhibitors
02/08/2006EP1623983A1 Heterocyclic compounds useful as DPP-IV inhibitors
02/08/2006EP1622613A2 Compounds, compositions and methods
02/08/2006CN1732146A Cycloalkyl inhibitors of potassium channel function
02/07/2006US6995284 Synthesis of selective androgen receptor modulators
02/02/2006WO2005112903A3 Use of ghrelin antagonists for improving cognition and memory
02/02/2006US20060025416 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
02/02/2006CA2573920A1 Histamine-3 receptor antagonists
02/01/2006EP1620412A2 Heterocyclic compounds and hydro isomers thereof
02/01/2006EP1476419B1 N-biphenylmethyl aminocycloalkanecarboxamide derivatives
01/2006
01/31/2006US6992096 translation of mRNA is allowed to continue past a nonsense mutation point, resulting in the production of a full length protein; genetic disorders; 3-(5-p-tolyl-[1,2,4]oxadiazol-3-yl)-benzoic acid
01/26/2006US20060020146 Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
01/26/2006US20060019998 Histamine-3 receptor antagonist
01/26/2006CA2574217A1 Diamine derivative, process of preparation thereof, and fungicide comprising diamine derivative as an active ingredient
01/25/2006EP1618169A1 Electron transport agents for organic electronic devices
01/25/2006EP1618098A2 1,2,4-oxadiazole benzoic acid compounds and their use for nonsense suppression and the treatment of disease
01/25/2006CN1726185A Formulations comprising selective androgen receptor modulators and using method thereof
01/24/2006US6989439 Exhibits excellent absorption characteristics, and which is high in fastness to light, heat, humidity, air, chemicals and the like
01/19/2006WO2006005909A1 Substituted acids for the treatment of respiratory diseases
01/19/2006US20060014836 e.g. 1-(Benzofuran-2-carbonyl-3-(3-phenoxy-phenyl)-thiourea;viricides; hepatitis virus
01/19/2006US20060014743 Methods of preventing bacterial infections with florfenicol-type antibiotics
01/18/2006CN1723207A Inhibitors of histone deacetylase
01/18/2006CN1723193A Novel polycyclic compounds which modulate PPARgamma type receptors and cosmetic/pharmaceutical compositions comprised thereof
01/12/2006US20060009484 Novel polycyclic compounds which modulate PPARgamma type receptors and cosmetic/pharmaceutical compositions comprised thereof
01/12/2006CA2570318A1 Biaryl derivatives
01/11/2006EP1613610A1 Benzo 1,2,5 oxadiazoles and benzo 1,2,5 thiadiazoles useful as histopathological staining agents, imaging agents and biomarkers
01/11/2006EP1613609A1 Ethynyl containing electron transport agents and their use in organic luminescent devices
01/05/2006WO2006002284A1 Ubiquitin ligase inhibitors
01/05/2006WO2006000353A1 Method for producing 4-(benzimidazolylmethylamino)-benzamidines
01/05/2006US20060004064 Condensation of substituted diaminobenzene with 2-[4-(1,2,4-oxadiazol-5-on-3-yl)phenylamino]acetic acid; then hydrogenation; carbonylation with an alkylhalogen formate, in the presence of hexyl chloroformate; 4-(benzimidazol-2-ylmethylamino)benzamidine; prevention of deep vein thrombosis
1 ... 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 ... 72